Skip to main content

Table 3 Hazard ratios of survival through the clinicopathological characteristics by multivariate analysis in recurrent ovarian cancer patients

From: CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery

Characteristic

Overall survival

Progression free survival

HR

95% CI

HR

95% CI

FIGO stage

 I

1.000

Reference

1.00

Reference

 II

1.04

0.44–2.44

1.08

0.68-1.73

 III

1.62

0.67–4.88

1.21

0.27-5.40

 IV

2.27

1.83–6.69

1.72

1.66-4.46

Grade

1.93

0.84–4.36

2.49

1.05-2.94

Primary CRS

1.06

0.58–2.86

1.65

1.08–2.86

Secondary CRS

1.41

1.01–2.10

1.77

1.14-2.74

Ascites

1.79

1.05–3.04

1.83

1.03-3.27

Relapse/Nadir CA-125 level

1.00

1.00–1.01

1.00

1.00-1.01

  1. Abbreviations: HR, hazard ratio; CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; CRS, cytoreductive surgery.
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us